Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Amy D. Leptien"'
Autor:
Tara L. Davis, Betty Wang, Don Wilson, Kathleen Comyns, Janet Tamada, Margarita Lopatin, Jonathan Lee, Richard C. Eastman, Amy D. Leptien, Charles W. Wei
Publikováno v:
Diabetes Technology & Therapeutics. 6:357-367
Skin irritation due to iontophoresis may limit the frequency of use of devices for drug delivery or transdermal extraction of analytes of clinical interest. This study examined whether preapplication of corticosteroid preparations could reduce skin i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f11842778a43ea40259bbefacb36880
https://doi.org/10.1089/152091504774198052
https://doi.org/10.1089/152091504774198052
Autor:
Helen Paguntalan, Laura M. Gandrud, Bruce A. Buckingham, Darrell M. Wilson, Richard C. Eastman, Michelle Van Wyhe, Amy D. Leptien, Betsy Kunselman
Publikováno v:
Pediatrics. 113:108-111
Background. Detection and prevention of nocturnal hypoglycemia is a major medical concern at diabetes camps. Objective. We conducted an open-label trial of the Cygnus GlucoWatch biographer to detect nocturnal hypoglycemia in a diabetes camp, a noncli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594ae71738743899a9d70668a8d34c4e
https://doi.org/10.1542/peds.113.1.108
https://doi.org/10.1542/peds.113.1.108
Publikováno v:
Pediatric Diabetes. 4:82-86
Objective: To conduct a preliminary analysis of the cost-effectiveness of the use of the GlucoWatch® Biographer in the management of type 1 diabetes in children and adolescents. Methods: The computer model used to analyze the cost-effectiveness of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd58c4196ca8e0ab56f7978fab5afab0
https://doi.org/10.1034/j.1399-5448.2003.00011.x
https://doi.org/10.1034/j.1399-5448.2003.00011.x
Autor:
Gheda Sahyun, Steven J. Fermi, H. Peter Chase, Margarita Lopatin, Michelle Van Wyhe, Barry H. Ginsberg, Charles W. Wei, Lee Fuller-Byk, Miroslaw Bartkowiak, Kenneth R. Pitzer, Henk Pechler, Tara L. Davis, Betty Y. Wang, Eba Hathout, Janet Tamada, Bruce A. Buckingham, Richard C. Eastman, Amy D. Leptien
Publikováno v:
Pediatric Diabetes. 3:127-134
Objective: This study was done to evaluate the accuracy and safety of measuring glucose with the GlucoWatch® biographer in children and adolescents with diabetes. Methods: Accuracy was assessed by comparing biographer glucose measurements with hourl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4cd592a8a1e948b2fd853b81f42ff44
https://doi.org/10.1034/j.1399-5448.2002.30302.x
https://doi.org/10.1034/j.1399-5448.2002.30302.x
Autor:
Betty Wang, Christina Southern, Margarita Lopatin, Long Tran, Richard C. Eastman, Reginald Anderson, Julie Hill, John W. Mace, Merrilee Hadley-Scofield, Eba Hathout, Jeannine Sharkey, Nina Patel, Amy D. Leptien
Publikováno v:
Pediatrics. 115(3)
Objective. To evaluate usability, accuracy, and hypoglycemia detection of the GlucoWatch G2 Biographer (GW2B) in children aged 1 to 17 years. Methods. After a 15-hour study of device accuracy, 46 children (15 Results. A total of 531 paired GW2B/meter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da78d03364051ae194fc1574d9d2a80d
https://pubmed.ncbi.nlm.nih.gov/15741369
https://pubmed.ncbi.nlm.nih.gov/15741369
Publikováno v:
Pediatric diabetes. 4(2)
To conduct a preliminary analysis of the cost-effectiveness of the use of the GlucoWatch Biographer in the management of type 1 diabetes in children and adolescents.The computer model used to analyze the cost-effectiveness of intensive diabetes treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff99abfb58fb61b58412297c2c13aa1c
https://pubmed.ncbi.nlm.nih.gov/14655264
https://pubmed.ncbi.nlm.nih.gov/14655264
Autor:
Janet A. Tamada, Tara L. Davis, Amy D. Leptien, Jonathan Lee, Betty Wang, Margarita Lopatin, Charles Wei, Don Wilson, Kathleen Comyns, Richard C. Eastman
Publikováno v:
Diabetes Technology & Therapeutics; 6/01/2004, Vol. 6 Issue 3, p357-367, 11p